Tokushima, Japan

Toshio Sato

This inventor holds 3 USPTO granted patents. Top assignees: Dainippon Ink and Chemicals, Incorporated, Nippon Hypox Laboratories Inc., Mochida Pharmaceutical Co., Ltd.. Active years: 1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshio Sato. Retrieved from https://idiyas.com/inventor/toshio-sato-mx04teyi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshio Sato

Introduction

Toshio Sato, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceuticals. With a total of three patents to his name, Sato has focused on developing innovative solutions to common medical challenges, particularly those associated with the side effects of cancer treatments.

Latest Patents

One of his latest patents includes an antiallergic agent designed to mitigate the side effects of platinum-containing drugs, such as cisplatinum. This pharmaceutical composition, which contains the effective component ulinastatin, aims to relieve kidney dysfunction, a serious side effect often experienced by patients undergoing treatment with these drugs. His work addresses a critical need in the medical community to improve patient outcomes during cancer treatment.

Career Highlights

Throughout his career, Toshio Sato has collaborated with notable companies, including Dainippon Ink and Chemicals Limited and Nippon Hypox Laboratories Inc. His extensive research and development efforts have positioned him as an influential figure in the pharmaceutical industry, contributing to advancements in drug efficacy and safety.

Collaborations

Sato has worked alongside esteemed colleagues, including Hitoshi Matsumoto and Hisao Kakegawa. Their collaborative efforts have fostered a synergistic approach in addressing complex medical challenges, leading to breakthroughs in pharmaceutical innovation.

Conclusion

Toshio Sato’s inventions have the potential to significantly enhance the quality of life for patients undergoing chemotherapy. His commitment to creating effective pharmaceutical solutions serves as an inspiration for future inventors and innovators in the field. As the medical landscape continues to evolve, Sato's contributions will undoubtedly leave a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…